DAWN DOMENECH: Open Payments
NPI 1093171456 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 18 payments from 9 companies in 2025. Trend: 2023 $286 · 2024 $329 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| Novo Nordisk Inc | 3 | $67 |
| Exact Sciences Corporation | 2 | $46 |
| Lilly USA, LLC | 2 | $34 |
| Boston Scientific Corporation | 1 | $30 |
| ABBVIE INC. | 1 | $18 |
| Smith+Nephew, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $15 |
Products named: Kerendia, Cologuard Collection Kit, Ozempic, MOUNJARO, WaveWriter Alpha Prime 16, Biktarvy, QULIPTA, COLLAGENASE SANTYL.
Industry payments across AZ — which companies pay providers there.
